Please use this identifier to cite or link to this item:
|Title:||Reply to von Reyn and Horsburgh|
|Publisher:||Oxford University Press Inc.|
|Abstract:||The study by Muñoz et al  demonstrates that the need for treatment of healthy household contacts of active tuberculosis can be safely reduced by 20% when an interferon γ release assay is used to exclude false-positive tuberculin skin test (TST) results. Because the study was conducted in Spain, 28% of trial participants had been previously immunized with Bacille Calmette Guerin (BCG) vaccine, a factor that seemed to be the predominant cause of false-positive TST results. The authors surmise that the remaining proportion of false-positive results may have been due to exposure to nontuberculous mycobacteria (NTM).|
|Note:||Reproducció del document publicat a: https://doi.org/10.1093/cid/ciy291|
|It is part of:||Clinical Infectious Diseases, 2018, vol. 67, num. 8, p. 1308-1309|
|Appears in Collections:||Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.